ANAPLASTIC THYROID CARCINOMAS
Clinical trials for ANAPLASTIC THYROID CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CARCINOMAS trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers left behind by modern medicine
Disease control Recruiting nowThis French study is testing whether a combination of two immunotherapy drugs can help control five types of advanced rare cancers that have progressed after standard treatment. It will enroll 154 adults whose cancers have specific rare origins, such as certain mesotheliomas, thy…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Living Drug' trial targets multiple advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune cell therapy (CAR-T) for people with advanced solid tumors that have a specific marker called CD70. The main goals are to find a safe dose and see how the body handles the treatment. It is for adults with cancers…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC